WASHINGTON TRUST ADVISORS, INC. Edwards Lifesciences Corporation Transaction History

WASHINGTON TRUST ADVISORS, INC. portfolio value:

$5.50M
portfolio value

WASHINGTON TRUST ADVISORS, INC. quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -3.74% -2.58K shares -1.07M $82.63 66.59K
Q2 2022 share Decrease -5.65% -4.14K shares -2.05M $95.09 69.17K
Q1 2022 share Decrease -1.14% -848 shares -978K $117.72 73.32K
Q4 2021 share Increase 0.00% 74.17K shares 9.60M $130.68 74.17K